Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Alain Li Wan Po"'
Publikováno v:
Emerging Infectious Diseases, Vol 15, Iss 10, Pp 1686-1687 (2009)
Externí odkaz:
https://doaj.org/article/3f500ce38dfb43e3a1a356d91b8befef
Autor:
Alain Li Wan Po
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics
What is known and Objective There has been astounding progress made in the treatment of disease over recent years. This progress is particularly marked in cell therapy and in the personalization of therapy based on genetic insight, an approach known
Autor:
Alain Li Wan Po
Publikováno v:
Journal of clinical pharmacy and therapeutics. 47(1)
Omicron is a variant of the COVID-19 virus that is causing considerable concern worldwide, with an increasing number of countries re-imposing national lockdowns. Our objective is to comment on its impact and to suggest that, threatening as it is, Omi
Autor:
Alain Li‐Wan‐Po
Publikováno v:
Journal of clinical pharmacy and therapeuticsREFERENCES. 47(1)
Autor:
Alain Li-Wan-Po, Gregory M. Peterson
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 46:1-3
What is known and objective: Every prescriber knows that patients often do not take their medicines as prescribed. Hippocrates, the wise man of Kos, knew over two millennia ago. Our objective is to comment on the types of studies aimed at understandi
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 38:36-40
Summary What is known and Objective: In analgesic trials, pain relief is often assessed using a pain-relief score. We aimed to assess, through a meta-analysis, whether absence of need for rescue medication (NNR) is a reliable outcome measure in the e
Publikováno v:
Evidence-Based Child Health: A Cochrane Review Journal. 6:1440-1544
Background Minocycline is a tetracycline antibiotic that is commonly used in the treatment of moderate to severe acne vulgaris. Although it is more convenient for patients to take than first-generation tetracyclines, as it only needs to be taken once
Publikováno v:
British Journal of Clinical Pharmacology. 69:222-230
AIMS Cytochrome P450 2C19 metabolizes many important drugs. In 2006, a variant allele (CYP2C19*17) associated with increased activity was discovered, but its likely clinical significance is controversial. Investigators disagree about the phenotype to
Publikováno v:
European Journal of Clinical Pharmacology. 66:369-374
To illustrate the interface of pharmacogenetics and therapeutic drug monitoring and to estimate target blood level for imatinib in the treatment of chronic myelogenous leukemiaA literature review to provide the evidence and necessary data to support
Autor:
Hywel C Williams, John Dada, William J. Cunliffe, Mara Ozolins, N.B. Simpson, Karen Williams, Anthony J Avery, Ciaran O'Neill, E. Anne Eady, Jennifer B Lewis, C.E. Walters, Mary Haynes, Alain Li Wan Po, Ellen Carnegie
Publikováno v:
The Lancet. 364:2188-2195
Summary Background We investigated the efficacy and cost-effectiveness of five antimicrobial regimens for mild to moderate facial acne and whether propionibacterial antibiotic resistance affects treatment response. Methods In this randomised, observe